A Prospective Multicenter Trial Evaluating Helios Biodegradable Polymer SES Safety and Effectiveness in CAD Treatment

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 800 participants.

Also called NCT01880879

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 800 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01880879
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01880879. Allocation not applicable; no masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2015-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Prospective Multicenter Trial Evaluating Helios Biodegradable Polymer SES Safety and Effectiveness in CAD Treatment
Acronym
Pro-HOPE
Intervention (Device)
helios stent
Lead sponsor
Kinhely Bio-tech Co., Ltd. (class: industry)
Collaborator
RenJi Hospital (class: other)
Collaborator
Peking University (class: other)

Record details

Record id
cardio:ct-nct01880879
Content hash
8fb5581a97128fc4fab089b3f7a484d5385cf9678a4428e6300d03f99ec0eb31